About these ads

Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘diabetes’ Category

Novartis Diovan scandal claims two more papers

with 5 comments

diabetes careA complicated story involving Novartis’s valsartan (Diovan) has led to the retraction of two more papers, one cascading from the other.

Last September, The Lancet retracted the Jikei Heart Study after a slew of retractions of related work prompted an investigation of valsartan research. That investigation found evidence of data manipulation and the failure of one researcher to note his Novartis affiliation. The company has apologized.

Here’s one retraction, from Diabetes Care, for “The Shiga Microalbuminuria Reduction Trial (SMART) Group. Reduction of Microalbuminuria in Patients With Type 2 Diabetes: The Shiga Microalbuminuria Reduction Trial (SMART):”

Read the rest of this entry »

About these ads

Misconduct at Oxford prompts retraction of insulin paper

with 7 comments

cellmetabcoverCell Metabolism has retracted a 2006 article by a group of researchers at Oxford in England after an investigation concluded that the first author had committed misconduct.

The paper, “Nicotinamide nucleotide transhydrogenase: A key role in insulin secretion,” came from the lab of Frances Ashcroft, a world-renowned expert on ion channels. (We’ve written about Ashcroft’s lab before.)

According to the abstract: Read the rest of this entry »

Written by amarcus41

February 5, 2014 at 10:32 am

“Personal rivalry” leads to retraction of nut-health paper

with 3 comments

ejpcHere’s a retraction that leaves us itching to know more:

The authors of a recent paper in the European Journal of Preventive Cardiology on nut intake and the risk of high blood pressure and diabetes have pulled their article from publication for an undisclosed conflict of interest.

Now, you wouldn’t know this unless you were willing to pony up the $32 to read the notice, which is behind a pay wall — something that drives us, well, nuts. But here it is:

Read the rest of this entry »

NEJM paper on sleep apnea retracted when original data can’t be found

with 4 comments

nejmThe authors of a paper in the New England Journal of Medicine are retracting it, after being unable to find data supporting a table that required corrections.

Here’s the notice: Read the rest of this entry »

Written by ivanoransky

October 30, 2013 at 5:00 pm

Journal withdraws diabetes paper written by apparently bogus authors

with 26 comments

BBRCTalk about a Trojan Horse.

Biochemical and Biophysical Research Communications has withdrawn a paper it published earlier this year on metabolic proteins linked to diabetes, not because the article was bogus but because the authors appear to have been. The work itself is accurate — indeed, it likely belongs to a Harvard scientist, Bruce Spiegelman, who’d presented his data on the subject several times recently and was in the process of preparing his results for publication. We’ve written about researchers trying to punk journals with faked articles, and about a researcher who apparently made up a co-author, but here’s something new!

Nature has the story. According to Nature, in July Spiegelman: Read the rest of this entry »

Frontiers papers on GMO debate, diabetes retracted for improperly cited text

with 5 comments

frontiers plantThe author of a review article on diabetes has been forced to retract the paper after it emerged that he failed to properly credit some of the text — an omission we generally associate with the word plagiarism.

The article, “Colonic flora, probiotics, obesity and diabetes,” was written by Paul Marik, of Eastern Virginia Medical School, and appeared in July 2012 in Frontiers in Endocrinology. It has been cited once, according to Thomson Scientific’s Web of Knowledge.

Here’s the retraction notice:

Read the rest of this entry »

BioMed Central retracts study it published twice while acquiring journal

leave a comment »

jdmdYesterday, we wrote about the retraction of a paper that ended up published despite the fact that peer reviewers had recommended rejecting it. Today, we have the (short) tale of a paper retracted because the publisher posted it a second time while they were buying acquiring the journal where it appeared.

Here’s the notice for “The association between depression, socio-economic factors and dietary intake in mothers having primary school children living in Rey, South of Tehran, Iran,” published in the Journal of Diabetes & Metabolic Diseases: Read the rest of this entry »

Written by ivanoransky

May 16, 2013 at 9:37 am

Diabetes paper retracted for “misgrouping errors” that remain under investigation

with 3 comments

diabetesA group of researchers at the University of Minnesota have retracted a paper in Diabetes for image problems, but exactly what happened is still under investigation.

Here’s the notice: Read the rest of this entry »

Written by ivanoransky

April 30, 2013 at 11:00 am

Mobile phone-diabetes study rings twice, earns retraction

leave a comment »

emriThe Journal of Diabetes and Metabolic Disorders has retracted a 2012 study by a group of Iranian researchers. The reason: the authors had published the paper three years earlier, in a different journal.

Here’s the notice for the article, titled “Mobile phone text messaging and Telephone follow-up in type 2 diabetic patients for 3 months: a comparative study”: Read the rest of this entry »

Authors retract Diabetes paper after submitting it “without knowledge of inherent errors”

with 39 comments

diabetesA group of neuroscientists has retracted a paper published earlier this last year in Diabetes after realizing that a figure that took up a whole page of the paper may not have been quite right.

Here’s the notice for “Blockade of receptor for advanced glycation end products in a model of type 1 diabetic leukoencephalopathy”: Read the rest of this entry »

Written by ivanoransky

January 7, 2013 at 12:27 pm


Get every new post delivered to your Inbox.

Join 31,341 other followers